Increased serum concentrations of pro-gastrin-releasing peptide in patients with renal dysfunction

Nephrology Dialysis Transplantation

Volumn 11, Issue 7, 1996, Pages 1267-1270

  Kamata, K ^a   Uchida, M ^a   Takeuchi, Y ^a   Takahashi, E ^a   Sato, N ^a   Miyake, Y ^a   Okubo, M ^b   Kodama, T ^c   Yamaguchi, K ^d  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Sano Welfare General Hospital   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Chronic renal failure; Pro gastrin releasing peptide; Renal dysfunction; Small cell lung carcinoma

Indexed keywords

PROGASTRIN; RELEASING FACTOR; TUMOR MARKER;

ADULT; ARTICLE; CHRONIC GLOMERULONEPHRITIS; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION TEST; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; UREA NITROGEN BLOOD LEVEL;

EID: 0030001177     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.7.1267     Document Type: Article

References (12)

1. Anastasi A, Erspamer V, Bucci M. Isolation and structure of bombesin and alytesin, two analogous active peptides from the skin of the European alytes. Experentia 1971; 27: 166-167
2. McDonald TJ, Ghatei MA, Bloom SR et al. A qualitative comparison of canine plasma gastroenteropancreatic hormone responses to bombesin and the porcine gastrin-releasing peptide(GRP). Regul Pept 1981; 2: 293-304
3. Bruzzone R, Tamburrano G, Lala A et al. Effect of bombesin on plasma insulin, pancreatic glucagon. and gut glucagon in man. J Clin Endocrinol Metab 1983; 56: 643-647
4. Nagalla SR, Gibson BW, Tang D, Reeve JR, Spindel ER. Gastrin-releasing peptide (GRP) is not mammalian bombesin. J Biol Chem 1992; 267: 6916-6922
5. Wharton J, Polak JM, Bloom SR et al. Bombesin-like immunoreactivity in the lung. Nature 1978; 273: 769-770
6. Track NS, Cutz E. Bombesin-like immunoreactivity in developing human lung. Life Sci 1982; 30: 1553-1556
7. Johnson DE, Lock JE, Elde RP, Thompson TR. Pulmonary neuroendocrine cells in hyaline membrane disease and bronchopulmonary dysplasia. Pediatr Res 1982; 16: 446-454
8. Yamaguchi K, Abe K, Kameya T et al. Production and molecular size heterogeneity of immunoreactive gastrin-releasing peptide in fetal and adult lungs and primary lung tumors. Cancer Res 1983; 43: 3932-3939
9. Maruno K, Yamaguchi K, Suzuki M et al. Immunoreactive gastrin-releasing peptide as a specific tumor marker in patients with small cell lung carcinoma. Cancer Res 1989; 49: 629-632
10. Yamaguchi K. Pro-gastrin-releasing peptide (31-98) is a specific tumor marker in patients with small cell lung carcinoma. Cancer Res 1994; 54: 2136-2140
11. Kodama T, Abe S, Yamaguchi K et al. Clinical significance for diagnosis of serum ProGRP by enzyme-linked immunosorbent assay (ELISA). Igaku to Yakugaku 1994; 32: 87-97 (in Japanese)
12. 2-microglobulin. Nephron 1981; 29: 30-35